Keywords: biotie, start, trials, new, anticoagulant, clinical, bioheparin

BioTie to start trials of new anticoagulant

Article | 28 January 2002

Clinical trials of BioHeparin, an antithrombotic agent developed byFinnish biotechnology company BioTie, are due to start in the current quarter ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Boehringer Ingelheim

Go to company listing

Related Drugs

Heparin

Go to drug listing